Moderna Cuts Vaccine Outlook, Qualcomm Shares Surge, Kyndryl Begins Trading
Carl Quintanilla, Jim Cramer and David Faber began the show with a look at Moderna shares sliding, after cutting its Covid-19 vaccine sales forecast. The company is now expecting to deliver between 700-800 million does this year, down from previous expectations of between 800 million and 1 billion doses. The anchors also interviewed Qualcomm CEO, Cristiano Amon, a day after the company reported a strong earnings beat. Qualcomm\u2019s chip sales for smartphones were up 56% year over year. Also in the mix: IBM spinoff Kyndryl began trading at the NYSE under ticker \u201cKD.\u201d CEO Martin Schroeter joined the crew ahead of the newly public company\u2019s first trade.